Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aldesleukin (Proleukin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
medroxyprogesterone (provera) (1 trial)
Carcinoma (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Trials (1 total)
Trial APIs (3 total)